Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,180,268 papers from all fields of science
Search
Sign In
Create Free Account
4-acetylaminobiphenyl
Known as:
N-(1,1'-biphenyl)-4-ylacetamide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Aminobiphenyl Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Mutagenicity of 4-aminobiphenyl and 4-acetylaminobiphenyl in Salmonella typhimurium strains expressing different levels of N-acetyltransferase.
L. N. Dang
,
C. Mcqueen
Toxicology and Applied Pharmacology
1999
Corpus ID: 23728217
4-Aminobiphenyl (4-ABP), an aromatic amine present in tobacco smoke, is an animal and human carcinogen. 4-ABP can undergo several…
Expand
1994
1994
Metabolic activation of N-hydroxy-4-acetylaminobiphenyl by cultured human breast epithelial cell line MCF 10A.
S. Swaminathan
,
S. M. Frederickson
,
J. Hatcher
Carcinogenesis
1994
Corpus ID: 26554154
Metabolism and nucleic acid binding of the mammary gland carcinogen N-hydroxy-4-acetylaminobiphenyl (N-OH-AABP) was investigated…
Expand
1992
1992
Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells.
S. Swaminathan
,
C. Reznikoff
Cancer Research
1992
Corpus ID: 41430667
Metabolic activation of N-hydroxy-4-acetylaminobiphenyl (N-OH-AABP) and N-acetoxy-4-acetylaminobiphenyl (N-OAc-AABP), the…
Expand
1992
1992
Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells.
S. M. Frederickson
,
J. Hatcher
,
C. Reznikoff
,
S. Swaminathan
Carcinogenesis
1992
Corpus ID: 45800171
Metabolism and nucleic acid binding of N-hydroxy-4-aminobiphenyl (N-OH-ABP), a proximate carcinogenic metabolite of the human…
Expand
1985
1985
Glucuronidation of carcinogenic arylamine metabolites by rat liver microsomes.
C. Y. Wang
,
K. Zukowski
,
M. Lee
Biochemical Pharmacology
1985
Corpus ID: 38652814
Highly Cited
1984
Highly Cited
1984
Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl, and 2-acetylaminophenanthrene.
R. Gupta
,
N. Dighe
Carcinogenesis
1984
Corpus ID: 27087916
Formation and removal of hepatic DNA adducts was studied in male Sprague-Dawley rats following single injections of two…
Expand
1975
1975
The reduction of N-hydroxy-4-acetylaminobiphenyl by the intestinal microflora of the rat.
L. Wheeler
,
F. Soderberg
,
P. Goldman
Cancer Research
1975
Corpus ID: 5826621
The role of the intestinal flora in the conversion of N-hydroxy-4-acetyl-aminobiphenyl (N-OH-AABP) to 4-acetylaminobiphenyl has…
Expand
Highly Cited
1975
Highly Cited
1975
Cytotoxicity of carcinogenic aromatic amides in normal and xeroderma pigmentosum fibroblasts with different DNA repair capabilities.
V. Maher
,
N. Birch
,
J. R. Otto
,
J. J. MacCormick
Journal of the National Cancer Institute
1975
Corpus ID: 10410062
The effect of exposure to UV irradiation or to the N-acetoxy-ester derivatives of four carcinogenic aromatic amides, 4…
Expand
1963
1963
A COMPARISON OF THE PATHOLOGICAL EFFECTS OF 2-ACETYLAMINOFLUORENE, 4-ACETYLAMINOBIPHENYL, AND 2-ACETYLAMINOBIPHENYL IN THE DOG.
A. G. Jabara
Cancer Research
1963
Corpus ID: 27708283
Summary The oral administration of 2-acetylaminofluorene (2-AAF) to seven bitches was followed by epithelial hyperplasia in the…
Expand
Highly Cited
1961
Highly Cited
1961
The N-Hydroxylation of 4-Acetylaminobiphenyl by the Rat and Dog and the Strong Carcinogenicity of N-Hydroxy-4-acetylaminobiphenyl in the Rat
J. Miller
,
Carole S. Wyatt
,
E. Miller
,
H. A. Hartmann
1961
Corpus ID: 19529048
Summary N -Hydroxy-4-acetylaminobiphenyl has been identified as a urinary metabolite of the carcinogens 4-acetylaminobiphenyl and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE